Product Information
Descyclopropyl lenvatinib is a synthetic drug candidate that is being developed for the treatment of cancer. It is a metabolite of lenvatinib and has shown to have similar pharmacological activity, including inhibition of protein synthesis. Descyclopropyl lenvatinib also has been shown to inhibit the metabolism of other drugs, such as irinotecan, which may be due to its ability to inhibit cytochrome P450 enzymes.
Chemical properties
Technical inquiry about: 3D-SRA71951 Descyclopropyl lenvatinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.